JP2000511175A5 - - Google Patents

Download PDF

Info

Publication number
JP2000511175A5
JP2000511175A5 JP1997542377A JP54237797A JP2000511175A5 JP 2000511175 A5 JP2000511175 A5 JP 2000511175A5 JP 1997542377 A JP1997542377 A JP 1997542377A JP 54237797 A JP54237797 A JP 54237797A JP 2000511175 A5 JP2000511175 A5 JP 2000511175A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP1997542377A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000511175A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/006801 external-priority patent/WO1997044315A1/en
Publication of JP2000511175A publication Critical patent/JP2000511175A/ja
Publication of JP2000511175A5 publication Critical patent/JP2000511175A5/ja
Abandoned legal-status Critical Current

Links

JP09542377A 1996-05-17 1997-04-24 ビフェニルスルホンアミドマトリックスメタロプロテイナーゼ阻害剤 Abandoned JP2000511175A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1746096P 1996-05-17 1996-05-17
US60/017,460 1996-05-17
PCT/US1997/006801 WO1997044315A1 (en) 1996-05-17 1997-04-24 Biphenylsulfonamide matrix metalloproteinase inhibitors

Publications (2)

Publication Number Publication Date
JP2000511175A JP2000511175A (ja) 2000-08-29
JP2000511175A5 true JP2000511175A5 (cg-RX-API-DMAC10.html) 2005-01-13

Family

ID=21782716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09542377A Abandoned JP2000511175A (ja) 1996-05-17 1997-04-24 ビフェニルスルホンアミドマトリックスメタロプロテイナーゼ阻害剤

Country Status (22)

Country Link
EP (1) EP0901466B1 (cg-RX-API-DMAC10.html)
JP (1) JP2000511175A (cg-RX-API-DMAC10.html)
KR (1) KR20000011095A (cg-RX-API-DMAC10.html)
CN (1) CN1077885C (cg-RX-API-DMAC10.html)
AT (1) ATE207891T1 (cg-RX-API-DMAC10.html)
BG (1) BG63940B1 (cg-RX-API-DMAC10.html)
BR (1) BR9710841A (cg-RX-API-DMAC10.html)
CA (1) CA2253342A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ294063B6 (cg-RX-API-DMAC10.html)
DE (1) DE69707865T2 (cg-RX-API-DMAC10.html)
DK (1) DK0901466T3 (cg-RX-API-DMAC10.html)
EA (1) EA001561B1 (cg-RX-API-DMAC10.html)
EE (1) EE03965B1 (cg-RX-API-DMAC10.html)
ES (1) ES2167733T3 (cg-RX-API-DMAC10.html)
IL (1) IL126832A0 (cg-RX-API-DMAC10.html)
NO (1) NO312510B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ332711A (cg-RX-API-DMAC10.html)
PL (1) PL186416B1 (cg-RX-API-DMAC10.html)
PT (1) PT901466E (cg-RX-API-DMAC10.html)
SK (1) SK282863B6 (cg-RX-API-DMAC10.html)
WO (1) WO1997044315A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA974223B (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2193691A1 (en) * 1994-06-22 1995-12-28 Andrew Miller Metalloproteinase inhibitors
US6124333A (en) * 1995-06-22 2000-09-26 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
CA2263886A1 (en) * 1996-12-09 1998-06-18 Warner-Lambert Company Method for treating and preventing heart failure and ventricular dilatation
US6340709B1 (en) 1996-12-17 2002-01-22 Warner-Lambert Company Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
SI0946166T1 (en) * 1996-12-17 2004-06-30 Warner-Lambert Company Llc Use of matrix metalloproteinase inhibitors for promoting wound healing
GB9706255D0 (en) 1997-03-26 1997-05-14 Smithkline Beecham Plc Novel compounds
DE19719621A1 (de) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren
AU737218B2 (en) * 1997-07-22 2001-08-09 Shionogi & Co., Ltd. Composition for treating or preventing glomerulopathy
KR20010033473A (ko) * 1997-12-23 2001-04-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 Ace 저해제-mmp 저해제의 병용 제제
US6410580B1 (en) 1998-02-04 2002-06-25 Novartis Ag Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
EP1053226A1 (en) * 1998-02-04 2000-11-22 Novartis AG Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
KR20010041916A (ko) * 1998-03-17 2001-05-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 스타틴-매트릭스 메탈로프로테이나제 저해제 복합제제
EP0967201A1 (en) * 1998-05-20 1999-12-29 Roche Diagnostics GmbH Pharmaceutical agents containing sulfonamids as matrix metalloproteinase inhibitors
CA2337828C (en) * 1998-07-16 2010-08-17 Aventis Pharma Deutschland Gmbh Phosphinic and phosphonic acid derivatives used as pharmaceuticals
CZ2001126A3 (cs) * 1998-07-21 2002-01-16 Warner-Lambert Company Společné účinky ACAT a MMP inhibitorů při léčbě aterosklerotických lézí
DE19851184A1 (de) * 1998-11-06 2000-05-11 Aventis Pharma Gmbh N-Arylsulfonyl-aminosäure-omega-amide
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
KR20010113820A (ko) * 1999-04-19 2001-12-28 시오노 요시히코 옥사디아졸 고리를 갖는 술폰아미드 유도체
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
DK1249233T3 (da) 1999-11-26 2008-11-17 Shionogi & Co NPYY5-antagonister
WO2002028844A1 (en) * 2000-09-29 2002-04-11 Shionogi & Co., Ltd. Thiazole or oxazole derivatives
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
MXPA01013326A (es) 2001-02-14 2002-08-26 Warner Lambert Co Bifenil sulfonamidas utiles como inhibisdores de metaloproteinasa de matriz.
WO2003035610A1 (en) * 2001-10-26 2003-05-01 Shionogi & Co., Ltd. Sulfonamide derivative having mmp inhibitory activity
GB0314488D0 (en) * 2003-06-20 2003-07-23 Glaxo Group Ltd Therapeutically useful compounds
JP2007525406A (ja) 2003-12-04 2007-09-06 ワイス ビアリールスルホンアミドおよびその使用方法
ATE449760T1 (de) * 2004-03-22 2009-12-15 Southern Res Inst Nichtpeptidinhibitoren von matrixmetalloproteinasen
CN101279956B (zh) * 2008-04-25 2011-06-15 南昌大学 一种基质金属蛋白酶抑制剂及合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506242A (en) * 1993-01-06 1996-04-09 Ciba-Geigy Corporation Arylsufonamido-substituted hydroxamic acids
CA2193691A1 (en) * 1994-06-22 1995-12-28 Andrew Miller Metalloproteinase inhibitors

Similar Documents

Publication Publication Date Title
JP2000502280A5 (cg-RX-API-DMAC10.html)
JP2000501771A5 (cg-RX-API-DMAC10.html)
JP2000501599A5 (cg-RX-API-DMAC10.html)
JP2000501018A5 (cg-RX-API-DMAC10.html)
JP2000500076A5 (cg-RX-API-DMAC10.html)
JP2000501324A5 (cg-RX-API-DMAC10.html)
JP2000500055A5 (cg-RX-API-DMAC10.html)
JP2000502472A5 (cg-RX-API-DMAC10.html)
JP2000501825A5 (cg-RX-API-DMAC10.html)
JP2000501338A5 (cg-RX-API-DMAC10.html)
JP2000500874A5 (cg-RX-API-DMAC10.html)
JP2000502425A5 (cg-RX-API-DMAC10.html)
JP2000502485A5 (cg-RX-API-DMAC10.html)
JP2000502568A5 (cg-RX-API-DMAC10.html)
JP2000501774A5 (cg-RX-API-DMAC10.html)
JP2000500912A5 (cg-RX-API-DMAC10.html)
JP2000502570A5 (cg-RX-API-DMAC10.html)
JP2000501876A5 (cg-RX-API-DMAC10.html)
JP2000501744A5 (cg-RX-API-DMAC10.html)
JP2000501229A5 (cg-RX-API-DMAC10.html)
JP2000502316A5 (cg-RX-API-DMAC10.html)
JP2000500857A5 (cg-RX-API-DMAC10.html)
JP2000502714A5 (cg-RX-API-DMAC10.html)
JP2000511175A5 (cg-RX-API-DMAC10.html)
JP2000501569A5 (cg-RX-API-DMAC10.html)